Content
Starbucks Earnings Report: Revenue Misses Expectations, EPS Declines, Stock Drops
Article By:
Charles Thuo
Read
Tuesday, April 30, 2024 5:07 PM EDT
Starbucks reported Non-GAAP EPS of $0.68, missing expectations by $0.12.
In this article: SBUX
Amazon Swings Wildly After Reporting Blowout AWS Results But Revenue Guidance Disappoints
Article By:
Tyler Durden
Read
Tuesday, April 30, 2024 4:49 PM EDT
EPS 98c vs $1 q/q, and beating estimates of 83c. Operating income $15.31 billion vs. $4.77 billion y/y, smashing estimates of $10.95 billion.
In this article: AMZN
S&P 500 Earnings Dashboard 24Q1 - Tuesday, April 30
Article By:
Lipper Alpha Insight
Read
Tuesday, April 30, 2024 2:03 PM EDT
The 24Q1 Y/Y blended revenue growth estimate is 3.7%. If the energy sector is excluded, the growth rate for the index is 4.2%.
3M’s Q1 Shows Marginal Sales Decline Offset By Strong Operational Performance
Article By:
The Tokenist
Read
Tuesday, April 30, 2024 8:12 AM EDT
3M has reported its Q1 results, with slight declines in sales but significant improvements in operational performance and earnings.
In this article: MMM
McDonald’s Earnings: Revenues Hit, While EPS Misses The Mark In Q1 Financial Results
Article By:
Invezz
Read
Tuesday, April 30, 2024 7:17 AM EDT
This morning, McDonald's posted its latest financial results.
The odds were stacked against the food chain, including economic headwinds.
The company's revenues were in line with expectations, although EPS was slightly lower than expected.
In this article: MCD
Time To Buy Amazon's Stock As Q1 Earnings Approach?
Article By:
Zacks Investment Research
Read
Tuesday, April 30, 2024 3:00 AM EDT
After Alphabet’s exhilarating quarterly results last week, Wall Street will be eying its big tech peer and cloud computing rival Amazon’s Q1 report on Tuesday, April 30.
Markets Up On Tesla, Q1 Earnings; Q1 Beats After The Bell
Article By:
Mark Vickery
Read
Tuesday, April 30, 2024 2:00 AM EDT
Market indices finished in the green across the board this Monday. It’s now the third straight day higher going back to Thursday of last week, and recovered from a quick drop into the red (mostly) roughly a half-hour prior to Monday’s close.
META: Spending Worries Trip Up Market Sentiment, But Bullish Outlook Prevails
Article By:
MoneyShow.com
Read
Tuesday, April 30, 2024 12:20 AM EDT
Is there anything more meta than the thing that’s supposed to drive a company’s future growth being the exact thing that trips it up? Because that’s exactly what we saw during this week’s results from Meta Platforms Inc.
Apple Earnings: Time To Take A Bite?
Article By:
Derek Lewis
Read
Monday, April 29, 2024 8:05 PM EDT
Apple is slated to unveil quarterly results. Shares have been considerably weak year-to-date, losing roughly 10% compared to the S&P 500’s 8% gain. Let’s examine expectations and a few key metrics to watch in the release.
In this article: AAPL
MicroStrategy Bought 25,250 Bitcoins In Q1
Article By:
Wajeeh Khan
Read
Monday, April 29, 2024 4:46 PM EDT
MicroStrategy reported its financial results for the first quarter today.
In this article: MSTR
S&P 500 Earnings Dashboard 24Q1 - Monday, April 29
Article By:
Lipper Alpha Insight
Read
Monday, April 29, 2024 4:24 PM EDT
The 24Q1 Y/Y blended revenue growth estimate is 3.8%. If the energy sector is excluded, the growth rate for the index is 4.4%.
The S&P Stalls At Its 50 DMA Ahead Of A Huge Week
Article By:
Greg Feirman
Read
Monday, April 29, 2024 4:00 PM EDT
There is a lot of confusion about the economy, inflation, and rates at the moment so investors will be hanging on Powell’s every word as usual.
Russell 2000 Q1 2024 Earnings Preview: Sharp Downward Revisions Precede Earnings Season
Article By:
Lipper Alpha Insight
Read
Monday, April 29, 2024 1:10 PM EDT
Looking ahead to 2024, both earnings and revenue growth expectations have been declining since August, now standing at 20.7% for full-year earnings.
In this article: IWM
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Article By:
Zacks Investment Research
Read
Sunday, April 28, 2024 4:00 PM EDT
The first-quarter 2024 earnings season picked up pace this week, with Merck, Sanofi, Novartis, and AstraZeneca announcing their first-quarter results. Three of the four companies beat estimates for both earnings and sales in the first quarter.